Search Results
69 items found for "Jana Selent"
- Ep 82 with Dr. Lauren M. Slosky
linking distinct signaling pathways with their physiological effects and may serve as the basis for more selective the Slosky Lab is now working to understand how the principles of receptor allosterism and functional selectivity
- GPCR Retreat 2023 - Part I
role at Orion Biotechnology, I work at the intersection of science and business, which includes target selection linking distinct signaling pathways with their physiological effects and may serve as the basis for more selective the Slosky Lab is now working to understand how the principles of receptor allosterism and functional selectivity
- GPCR Retreat 2023 | Dr. GPCR Ecosystem
Additionally, each symposium of the GPCR Retreat 2023 will include one trainee short talk selected from encouraged to register to the meeting and submit an abstract for consideration for the trainee symposia and selected
- Ep 64 with Dylan Eiger
phosphorylation (phosphorylation barcodes) and subcellular GPCR signaling in directing functionally selective
- Ep 79 with Dr. Graeme Milligan
His experience also includes translating knowledge generated into the selection of targets, screening
- Logo Contest for Adhesion GPCR Workshop 2024 | Dr. GPCR Ecosystem
deadline will not be considered) Designs or inquiries should be sent to this email The prize for the selected
- Ep 63 with Dr. Khaled Abdelrahman
He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and
- The power of many: Multilevel targeting of representative chemokine and metabolite GPCRs in personalized cancer therapy
This review offers a focused examination of selected protumorigenic chemokine and metabolite-sensing
- GPR68-ATF4 signaling is a novel prosurvival pathway in glioblastoma activated by acidic extracellular microenvironment
We use U87 and U138 glioblastoma cell lines to show how selective induction of ferroptosis occurs in These findings provide a promising therapeutic approach to selectively induce ferroptosis in glioblastoma
- A positive Allosteric Modulator of M1 Acetylcholine Receptors Improves Cognitive Deficits in Male and Female Alzheimer’s Mice
He has been also studying what aspects of GPCR signaling are regulated in a sex-selective manner and
- Chemoattractant receptor signaling in humoral immunity
However, the molecular mechanisms by which individual GRKs are selectively targeted to GPCRs have been
- GPCR Retreat Registration 2023 | Dr. GPCR Ecosystem
to register for the meeting and submit an abstract for consideration for the trainee symposium and selected
- The path of GPR87: from a P2Y-like receptor to its role in cancer progression
for therapeutic interventions using both humanized monoclonal antibodies and gene therapy but also selective
- Ep 87 with Dr. Bianca Plouffe
involved in the angiotensin type 2 receptor (AT2R)-mediated neurite outgrowth while characterizing new selective
- Small-molecule targeting of GPCR-independent noncanonical G-protein signaling in cancer
By revealing that small molecules can selectively disable noncanonical mechanisms of G-protein activation
- Observational Study of Repeat Immunoadsorption (RIA) in Post-COVID ME/CFS Patients with Elevated ß2-Adrenergic Receptor Autoantibodies-An Interim Report
The results of this observational study will provide the basis for patient selection for a randomised
- Ep 113 with Dr. Prasenjit Saha
modulators has gained attention as they have the potential to fine-tune cellular responses with greater selectivity
- Identification of Small-Molecule Antagonists Targeting the Growth Hormone Releasing Hormone Receptor (GHRHR)
Preliminary analysis of the specificity/selectivity of one of the most effective hit compounds indicated
- GPR143 controls ESCRT-dependent exosome biogenesis and promotes cancer metastasis
0 Subunit) and promotes its association to cargo proteins, such as EGFR, which subsequently enables selective demonstrate its ability to promote cancer cell motility. " Authors Yu Jin Lee , Kyeong Jin Shin , Hyun-Jun Jang
- LP2, a cyclic angiotensin-(1-7) analog extended with an N-terminal D-lysine, impairs growth of patient-derived xenografts of colorectal carcinoma in mice
together, the extremely low dose of LP2 at which antitumor activity is exerted, the synergism with selected
- Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells
KS-133, a newly developed VIPR2-selective antagonist peptide, attenuated VIP-induced cell proliferation
- In Silico Design of Novel RGS2-Galpha-q Interaction Inhibitors with Anticancer Activity
identified hits to RGS2 as well as other RGS structures was used to screen the hits for potent and selective
- Delivery of US28 by incoming HCMV particles rapidly attenuates Akt activity to suppress HCMV lytic replication in monocytes
US28 is a virally encoded G protein-coupled receptor (GPCR) that is essential for silent infections within
- Principles of Pharmacology in Drug Discovery II | Dr. GPCR Ecosystem
Recordings will be available < Back to GPCR courses Advanced Methods for the Optimization of Candidate Selection
- The Effect of Cancer-Associated Mutations on Ligand Binding and Receptor Function - A Case for the 5-HT2C Receptor
By filtering the sequencing data from the Genomic Data Commons data portal (GDC), we selected 12 mutations
- Evolutionary diversity of CXCL16-CXCR6: Convergent substitutions and recurrent gene loss in sauropsids
leukocyte adhesion by interacting with cell surface-expressed CXCL16 and plays a key role in G-protein selectivity
- Identification of a G-protein coupled receptor-related gene signature through bioinformatics analysis to construct a risk model for ovarian cancer prognosis
Prognostic GPCRRGs were screened using least absolute shrinkage and selection operator (LASSO) Cox regression
- The combination of brentuximab vedotin and chidamide synergistically suppresses the proliferation of T-cell lymphoma cells through the enhancement of apoptosis
Methods: A high-throughput screening test was used to select the most synergistic partner of BV from